Press release
United States Nucleic Acid Therapeutics Market Outlook 2025-2032: Navigating 10.9% CAGR Growth with Focus on Hospitals and Research Institutes, Oncology/Viral Focus, UK siRNA Trials, and Competitive Landscape of Gilead, Novartis, Sarepta
Nucleic Acid Therapeutics Market
According to DataM Intelligence has published a new research report on "Nucleic Acid Therapeutics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
📌 Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/nucleic-acid-therapeutics-market?rk
➣ Recent Developments:
United States: Recent Industry Developments - Nucleic Acid Therapeutics
✅ August 2025 - A major biotech company advanced its self-amplifying RNA (saRNA) platform into late-stage trials, targeting infectious diseases and oncology with improved durability and lower dosing needs.
✅ July 2025 - U.S. firms announced new CRISPR-based gene-editing therapies entering Phase 2, focused on rare genetic disorders such as transthyretin amyloidosis and sickle cell-related complications.
✅ June 2025 - A leading RNA therapeutics company launched a next-generation LNP delivery system designed to enhance tissue targeting, reduce immunogenicity, and enable extrahepatic delivery.
Europe: Recent Industry Developments - Nucleic Acid Therapeutics
✅ August 2025 - Germany: A European biotech launched its DNA-encoded therapeutic library platform, enabling faster discovery of nucleic acid drugs for oncology and immunology.
✅ July 2025 - UK: A new siRNA therapy for metabolic disorders entered Phase 3 trials, marking one of the fastest advancements in the region's nucleic acid pipeline.
✅ June 2025 - France: European researchers deployed an AI-optimized mRNA design engine to enhance mRNA structure, translation efficiency, and durability for next-gen vaccines and therapeutics.
➣ Top Industry Players:
Ionis Pharmaceuticals, Alnylam Pharmaceuticals, Inc., Gilead Sciences, Inc., AstraZeneca, Sarepta Therapeutics, Inc., Creative Biolabs, GSK plc, Novartis AG, BioNTech SE., and Silence Therapeutics.
📌 Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=nucleic-acid-therapeutics-market?rk
➣ Key Segments:
By category: Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Messenger RNA (mRNA), Self-Amplifying RNA (saRNA).
By application: Cancers, Viral Infections, Genetic Disorders, Others.
By end-user: Hospitals, Academic & Research Institutes.
📌 Get Customization in the report as per your requirements: https://datamintelligence.com/customize/nucleic-acid-therapeutics-market?rk
📌 Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/nucleic-acid-therapeutics-market?rk
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
☛ Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?rk
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Nucleic Acid Therapeutics Market Outlook 2025-2032: Navigating 10.9% CAGR Growth with Focus on Hospitals and Research Institutes, Oncology/Viral Focus, UK siRNA Trials, and Competitive Landscape of Gilead, Novartis, Sarepta here
News-ID: 4298583 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Bioprocess Automation and Control Software Market Outlook 2025-203 …
The Bioprocess Automation and Control Software Market reached US$4.96 billion in 2024 and is expected to reach US$13.59 billion by 2032, growing at a CAGR of 13.7% during the forecast period of 2025-2032, according to a DataM Intelligence report.
According to DataM Intelligence has published a new research report on "Bioprocess Automation and Control Software Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional…
United States Bioprocess Technology Market to Reach US$ 62.4 Billion by 2031, Dr …
Leander, Texas and TOKYO, Japan - Dec.3.2025 "Bioprocess Technology Market is anticipated to grow at high CAGR during the forecast period 2024-2031."
The Bioprocess Technology Market is experiencing significant expansion due to the increasing demand for monoclonal antibodies, recombinant proteins, and cell & gene therapies. Market growth is underpinned by technological advancements in single use systems, continuous bioprocessing, and process automation, alongside substantial R&D investments from both established pharmaceutical companies and…
United States Weight-Loss Devices Market Delivers Ounce-for-Ounce Results at 8.5 …
Leander, Texas and TOKYO, Japan - Dec. 03, 2025. According to DataM Intelligence, the United States Weight-Loss Devices Market Size is growing from USD 1.8 billion in 2023 to USD 2.8 billion by 2031, registering a robust CAGR of 8.5% during 2024-2031. The surging demand for minimally invasive obesity solutions, the expansion of bariatric adjunct therapies, and advancements in endoscopic implantation technologies are fueling the need for enhanced weight-loss device…
United States Nonylphenol Ethoxylates Market Packs Ounce-for-Ounce Efficiency at …
Leander, Texas and TOKYO, Japan - Dec. 03, 2025. According to DataM Intelligence, the United States Nonylphenol Ethoxylates Market Size is growing from USD 920 million in 2023 to USD 1.2 billion by 2031, registering a robust CAGR of 4.2% during 2024-2031. The surging demand for high-performance surfactants, the expansion of industrial cleaning applications, and advancements in eco-formulation technologies are fueling the need for enhanced nonylphenol ethoxylates (NPEs) that maximise…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
